Paquinimod-d5-1 is the deuterated form of Paquinimod. Paquinimod (ABR 215757) is an orally active, specific inhibitor of S100A8/S100A9, used in studying pneumonia by reducing viral load in mice infected with SARS-CoV-2.
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted